Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates

Details for Australian Patent Application No. 2001269762 (hide)

International Classifications

Event Publications

23 June 2005 Assignment before Grant

The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services; Kreitman, Robert J The application has been assigned to The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services

23 June 2005 Application Accepted

Published as AU-B-2001269762

4 August 2005 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 08 Jul 2005. Address for service in Australia - Davies Collison Cave Level 10 10 Barrack Street Sydney NSW 2000

20 October 2005 Standard Patent Sealed

22 December 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 08 Jul 2005 2002

13 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.